You have been chosen to receive this valuable information. |
|
|
|
|
|
Letter from ICON CEO
ICON's CEO Steve Cutler on the range of measures ICON has put in place to protect the safety of our employees, to ensure the continuity of clients’ research programmes and to help protect the welfare of patients.
|
|
|
COVID-19 clinical operations
ICON has a range of existing services that will support you to keep your clinical trial on track including Direct to Patient Contact Solutions, In-home & Alternative Site Clinical Services, remote monitoring and FIRECREST solutions to provide site and patient training remotely.
|
|
|
Coronavirus Observatory
To support clients in tracking the vast amount of information and reporting on COVID-19, we have established the Coronavirus Observatory, a free tool that applies AI analysis and data visualisation to COVID-19 news and social media, providing updates on the latest vaccine trials and insights into trending topics driving Coronavirus reporting.
|
|
|
|
|
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|
